Maura C. Danni

Ancona, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry.

Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry.

Journal: Journal of neurology

Published: August 08, 2023

Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY).

Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY).

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: July 11, 2023

Clinical relevance of thymic and bone marrow outputs in multiple sclerosis patients treated with alemtuzumab.

Clinical relevance of thymic and bone marrow outputs in multiple sclerosis patients treated with alemtuzumab.

Journal: Journal of neuroimmunology

Published: June 27, 2023

Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register.

Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: February 17, 2022

Impact of Dimethylfumarate on Sleep in Multiple Sclerosis Patients: An Actigraphic Study.

Impact of Dimethylfumarate on Sleep in Multiple Sclerosis Patients: An Actigraphic Study.

Journal: CNS & neurological disorders drug targets

Published: October 14, 2021

Potential prognostic value of circulating inflamma-miR-146a-5p and miR-125a-5p in relapsing-remitting multiple sclerosis.

Potential prognostic value of circulating inflamma-miR-146a-5p and miR-125a-5p in relapsing-remitting multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: April 19, 2021

Sleep in multiple sclerosis patients treated with interferon beta: an actigraphic study.

Sleep in multiple sclerosis patients treated with interferon beta: an actigraphic study.

Journal: Neurological research

Published: June 11, 2020

Long-term outcome in multiple sclerosis patients treated with fingolimod.

Long-term outcome in multiple sclerosis patients treated with fingolimod.

Journal: Multiple sclerosis and related disorders

Published: May 20, 2020

Cerebral hemodynamics in patients with multiple sclerosis.

Cerebral hemodynamics in patients with multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: May 09, 2020

Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study.

Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: November 21, 2019

Parvovirus B19 infection in a patient with multiple sclerosis treated with ocrelizumab.

Parvovirus B19 infection in a patient with multiple sclerosis treated with ocrelizumab.

Journal: Acta neurologica Belgica

Published: July 29, 2019

Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.

Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.

Journal: Frontiers in neurology

Published: February 11, 2019

Showing 1-12 of 21

Last Updated: 09/26/2026